U.S. flag An official website of the United States government
  1. Home
  2. Regulatory Information
  3. Search for FDA Guidance Documents
  4. Design Considerations and Pre-market Submission Recommendations for Interoperable Medical Devices
  1. Regulatory Information

GUIDANCE DOCUMENT

Design Considerations and Pre-market Submission Recommendations for Interoperable Medical Devices Guidance for Industry and Food and Drug Administration Staff September 2017

Final

Design Considerations and Pre-market Submission Recommendations for Interoperable Medical Devices

Docket Number:
FDA-2015-D-4852
Issued by:
Guidance Issuing Office
Center for Devices and Radiological Health

As electronic medical devices are increasingly connected to each other and to other technology, the ability of these connected systems to safely and effectively exchange and use the information that has been exchanged becomes increasingly important. Advancing the ability of medical devices to exchange and use information safely and effectively with other medical devices as well as other technology offers the potential to increase efficiency in patient care.

FDA intends to promote the development and availability of safe and effective interoperable medical devices. FDA is issuing this guidance to assist industry and FDA staff in identifying specific considerations related to the ability of electronic medical devices to safely and effectively exchange information and use exchanged information. This document highlights considerations that should be included in the development and design of interoperable medical devices and provides recommendations for the content of premarket submissions and labeling for such devices.


Submit Comments

You can submit online or written comments on any guidance at any time (see 21 CFR 10.115(g)(5))

If unable to submit comments online, please mail written comments to:

Division of Dockets Management (HFA- 305)
Food and Drug Administration
5630 Fishers Lane, Rm. 1061
Rockville, MD 20852

All written comments should be identified with this document's docket number: FDA-2015-D-4852.